Search Results for 'arv treatment'

arv treatment published presentations and documents on DocSlides.

Demand for ARV medicines in low and middle income countries will exceed 16 million person-years by
Demand for ARV medicines in low and middle income countries will exceed 16 million person-years by
by natalia-silvester
V. . Habiyambere. , . J. . Perriëns. , B. Dongmo...
Assoc.Prof
Assoc.Prof
by yoshiko-marsland
. . Thanyawee. . Puthanakit. , MD.. Division of ...
High-dose rifampicin
High-dose rifampicin
by pasty-toler
TB treatment regimen to . reduce . 12-month . mor...
Eliminating Perinatal HIV Transmission
Eliminating Perinatal HIV Transmission
by jane-oiler
A Curriculum for OB/GYN Resident and Midwifery Pr...
Scaling up what works: replicating models on community serv
Scaling up what works: replicating models on community serv
by yoshiko-marsland
Jennifer Gatsi Mallet. Namibia Women’s Health N...
New Directions in the 2015  Consolidated ARV Guidelines Update
New Directions in the 2015 Consolidated ARV Guidelines Update
by test
Meg . Doherty, MD, PhD, MPH. 19 July 2015. WHO Sa...
Clinical aspects of ADRs in HIV and ARV toxicity monitoring approaches
Clinical aspects of ADRs in HIV and ARV toxicity monitoring approaches
by myesha-ticknor
Clinical aspects of ADRs in HIV and ARV toxicity ...
WHO ARV Forecasting Meeting
WHO ARV Forecasting Meeting
by sistertive
Geneva, March 19 - 20 , 2015 1 | Treatment and C...
The Future of HIV Treatment
The Future of HIV Treatment
by myesha-ticknor
Greg Perry. Melbourne – International AIDS Conf...
Diagnosis and Initial Management of HIV/AIDS:
Diagnosis and Initial Management of HIV/AIDS:
by cheryl-pisano
What the Primary Care Provider Should Know. Carol...
Projecting  the Impact of
Projecting the Impact of
by marina-yarberry
Generic. HIV . Drugs. on 90-90-90. Esteban Burr...
Track B
Track B
by karlyn-bohler
Clinical Science, Treatment and Care. ZIMBABWE ...
Salim
Salim
by stefany-barnette
S Abdool Karim. Director. : CAPRISA. Pro Vice-Cha...
New Prevention Technologies Workshop
New Prevention Technologies Workshop
by karlyn-bohler
Module 1: . Basic definitions. www.icad-cisd.com....
Budget issues driving/affecting treatment choice:
Budget issues driving/affecting treatment choice:
by pamella-moone
Community involvement in the . London ARV tender ...
Innovative Strategies for the Management
Innovative Strategies for the Management
by karlyn-bohler
of HIV Infection. Dual therapies without NRTIs. J...
Rationalizing Pediatric ARV Formularies:
Rationalizing Pediatric ARV Formularies:
by marina-yarberry
The IATT Optimal Pediatric ARV List. . Presented...
Adolescent HIV Care and Treatment
Adolescent HIV Care and Treatment
by tatiana-dople
Module 11:. Family Planning and PMTCT Services fo...
Mechanisms to address IP related Barriers
Mechanisms to address IP related Barriers
by kittie-lecroy
. in . Middle-Income Countries. Othoman. Mellou...
Affordability of HIV/AIDS treatment in developing countries: modeling ARV drug price determinants f
Affordability of HIV/AIDS treatment in developing countries: modeling ARV drug price determinants f
by marina-yarberry
functioning. Luis . Sagaon. . Teyssier. ; Yves A...
 The ART of HIV Management:
The ART of HIV Management:
by briana-ranney
An Antiretroviral Therapy Review. Sarah Pérez, P...
 New Directions in  the future 2015
New Directions in the future 2015
by mitsue-stanley
Consolidated ARV Guidelines Update. Meg . Doherty...
CROI 2019:  ARV for Prevention and Treatment, HIV Pathogenesis, and Cure
CROI 2019: ARV for Prevention and Treatment, HIV Pathogenesis, and Cure
by brown
Joseph J. Eron, Jr, MD. Professor of Medicine. Uni...
ARV Resistance  1 Learning Objectives
ARV Resistance 1 Learning Objectives
by naomi
Define drug resistance. Identify . factors that in...
New drugs for individuals
New drugs for individuals
by Ziggystardust
with multi-resistant virus. 6 APRIL 2020. Faculty....
Module 1:  Principles of Viral Load Monitoring
Module 1: Principles of Viral Load Monitoring
by braylon
Learning Objectives. Understand the dynamics of vi...